Showing results (671-680 of 785) with videos related to
Sort By:
Pageof 79
Biorxiv : the Preprint Server for Biology|April 28, 2025
Small Accelerations of the cell generate sufficient nuclear motion to modulate transcriptional activity, driving cellular response independent of matrix strainNina Nikitina, Jonathan Wadsworth, Matthew Goelzer, et al.Journal of Crohn'S & Colitis|February 13, 2019
IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon CancersJoel Pekow, Kyle Hernandez, Katherine Meckel, et al.Clinical and Translational Science|November 24, 2025
Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel DiseaseNikhil Reddy, Jeremy A Klein, Nikita Thomas, et al.Inflammatory Bowel Diseases|October 22, 2022
Creation of an Inflammatory Bowel Disease Referral Pathway for Identifying Patients Who Would Benefit From Inflammatory Bowel Disease Specialist ConsultationFrank I Scott, Orna Ehrlich, Dallas Wood, et al.The American Journal of Gastroenterology|July 19, 2017
Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With VedolizumabAkihiro Yamada, Yuga Komaki, Nayan Patel, et al.Journal of Crohn'S & Colitis|May 12, 2025
Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitisGeert D'Haens, Silvio Danese, Remo Panaccione, et al.Inflammatory Bowel Diseases|May 22, 2019
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis FoundationK T Park, Orna G Ehrlich, John I Allen, et al.Inflammatory Bowel Diseases|May 2, 2009
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximabWaqqas Afif, Jonathan A Leighton, Stephen B Hanauer, et al.BMJ Open Gastroenterology|January 8, 2025
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitisSéverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, et al.Nature Communications|January 20, 2026
Low intensity vibration with zoledronate reduces musculoskeletal weakness and adiposity in estrogen deprived female miceGabriel M Pagnotti, Trupti Trivedi, Laura E Wright, et al.Pageof 79